Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Letter | 17 April 2026 Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Letter | 17 April 2026 Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement
Report | 09 April 2026 AfricaKenyaRwandaSouth Africa Shifting Global Health R&D Funding: Opportunities in a Changing Landscape
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Letter | 17 April 2026 Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement
Statement | 16 June 2026 Europe European Biotech Act Must Deliver Public-Interest Innovation and Equitable Access
Press release | 16 June 2026 Public investment demands public benefits: European Biotech Act must deliver for people
Statement | 18 May 2026 Open-ended Intergovernmental Working Group on the WHO Pandemic Agreement – WHA79/13.3
Statement | 18 May 2026 Follow-up to the political declaration of the high-level meeting of the General Assembly on the prevention and control of non-communicable diseases – WHA79/12.1
Press release | 18 May 2026 Urgent action needed to close devastating vaccination coverage gaps in conflict-affected settings
Press release | 15 May 2026 Countries must lay groundwork to turn Pandemic Agreement commitments into access for all
Letter | 17 April 2026 Open letter: Linking pathogens and data access to enforceable benefit-sharing commitments in the Pandemic Agreement
Press release | 20 February 2019 Intellectual property and trade United States of America Novartis secures FDA innovation prize for 30-year-old drug 4 min
Video Video | 08 February 2019 Tuberculosis India TB survivors challenge J&J's patent on TB drug in India
Photography by Atul Loke Press release Press release | 07 February 2019 Tuberculosis India TB activists for first time challenge TB drug patent in India 6 min
Statement | 31 January 2019 Antimicrobial resistance 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Antimicrobial resistance 2 min
Statement | 30 January 2019 Tuberculosis 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Ending tuberculosis 2 min
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines 2 min
UN Photo/Christopher Black Events Events | 29 January 2019 MSF statements at WHO Executive Board 144th session
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products: Cancer medicines 2 min
